It is interesting to note that although improvement in prophylaxis dosing frequency from thrice-weekly to twice-weekly was not statistically significant ( Table 3 ), it was still trending toward significance in our survey.
← all excerpts
Understanding patient preferences and willingness to pay for hemophilia therapies.
1
—
—